Evidence map›Paper›PMID 29773186›Full record

ArticleJournal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)2018

Association between cadmium and androgen receptor protein expression differs in prostate tumors of African American and European American men.

Christine M Neslund-Dudas, Russell B McBride, Ashoka Kandegedara, Benjamin A Rybicki, Oleksandr N Kryvenko, Dhananjay Chitale, Nilesh Gupta, Sean R Williamson, Craig G Rogers, Carlos Cordon-Cardo and 4 more

Abstract read
In one paragraph

Article in Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Smoking and the risk of prostate cancer: a review of risk and disease progression.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2025
    Review
  4. Article
  5. Mechanisms of Heavy Metal Cadmium (Cd)-Induced Malignancy.Biological trace element research · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Developmental toxicity of cadmium in infants and children: a review.Environmental analysis, health and toxicology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Christine M Neslund-DudasDepartment of Public Health Sciences, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States; Henry Ford Cancer Institute, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States. Electronic address: cdudas1@hfhs.org.
Russell B McBrideDepartment of Pathology, Icahn School of Medicine at Mount Sinai, 1428 Madison Avenue, 15th Floor, New York, NY 10029, United States.
Ashoka KandegedaraDepartment of Biochemistry & Molecular Biology, Wayne State University School of Medicine, 540 E. Canfield Avenue, Detroit, MI 48201, United States.
Benjamin A RybickiDepartment of Public Health Sciences, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States; Henry Ford Cancer Institute, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States.
Oleksandr N KryvenkoDepartments of Pathology and Laboratory Medicine, Department of Urology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, 1400 NW 12th Avenue, East Bldg, 4th Floor, Miami, FL 33136, United States.
Dhananjay ChitaleHenry Ford Cancer Institute, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States; Department of Pathology, Henry Ford Health System, 2799 West Grand Blvd., Detroit, MI, 48202, United States.
Nilesh GuptaHenry Ford Cancer Institute, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States; Department of Pathology, Henry Ford Health System, 2799 West Grand Blvd., Detroit, MI, 48202, United States.
Sean R WilliamsonHenry Ford Cancer Institute, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States; Department of Pathology, Henry Ford Health System, 2799 West Grand Blvd., Detroit, MI, 48202, United States.
Craig G RogersHenry Ford Cancer Institute, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States; Department of Urology, Henry Ford Health System, 2799 West Grand Blvd., Detroit, MI, 48202, United States.
Carlos Cordon-CardoDepartment of Pathology, Icahn School of Medicine at Mount Sinai, 1428 Madison Avenue, 15th Floor, New York, NY 10029, United States.
Andrew G RundleMailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, United States.
Albert M LevinDepartment of Public Health Sciences, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States; Henry Ford Cancer Institute, Henry Ford Health System, One Ford Place, Suite 5C, Detroit, MI 48202, United States.
Q Ping DouDepartments of Oncology, Pharmacology and Pathology, and Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, 4100 John R, Detroit, MI, 48201, United States.
Bharati MitraDepartment of Biochemistry & Molecular Biology, Wayne State University School of Medicine, 540 E. Canfield Avenue, Detroit, MI 48201, United States.
Henry Ford Health System · USWayne State University · USIcahn School of Medicine at Mount Sinai · USColumbia University · USSylvester Comprehensive Cancer Center · US

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI Julie Lynn Boerner · 1985 to 2026
$68.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024156 · NCRR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2006 to 2011
$53.0M
GENE-ENVIRONMENT INTERACTION IN PROSTATE CANCERR01ES011126 · NIEHS · HENRY FORD HEALTH SYSTEM · PI RYBICKI, BENJAMIN A. · 2000 to 2017
$8.0M
Exploration of Cadmium as an Endocrine Disruptor in Prostate Cancer DisparitiesR21ES024379 · NIEHS · HENRY FORD HEALTH SYSTEM · PI NESLUND-DUDAS, CHRISTINE MARIE · 2014 to 2015
$424k
NCI NIH HHS P30 CA022453NCRR NIH HHS UL1 RR024156NIEHS NIH HHS R01 ES011126NIEHS NIH HHS R21 ES024379
6 · The paper itself

Abstract

Cadmium is a known carcinogen that has been implicated in prostate cancer, but how it affects prostate carcinogenesis in humans remains unclear. Evidence from basic science suggests that cadmium can bind to the androgen receptor causing endocrine disruption. The androgen receptor is required for normal prostate development and is the key driver of prostate cancer progression. In this study, we examined the association between cadmium content and androgen receptor protein expression in prostate cancer tissue of African American (N = 22) and European American (N = 30) men. Although neither overall tumor cadmium content (log transformed) nor androgen receptor protein expression level differed by race, we observed a race-cadmium interaction with regard to androgen receptor expression (P = 0.003) even after accounting for age at prostatectomy, smoking history, and Gleason score. African American men had a significant positive correlation between tumor tissue cadmium content and androgen receptor expression (Pearson correlation = 0.52, P = 0.013), while European Americans showed a non-significant negative correlation between the two (Pearson correlation = -0.19, P = 0.31). These results were unchanged after further accounting for tissue zinc content or dietary zinc or selenium intake. African American cases with high-cadmium content (>median) in tumor tissue had more than double the androgen receptor expression (0.021 vs. 0.008, P = 0.014) of African American men with low-cadmium level. No difference in androgen receptor expression was observed in European Americans by cadmium level (high 0.015 vs. low 0.011, P = 0.30). Larger studies are needed to confirm these results and if upheld, determine the biologic mechanism by which cadmium increases androgen receptor protein expression in a race-dependent manner. Our results suggest that cadmium may play a role in race disparities observed in prostate cancer.

Indexed as

Black or African AmericanCadmiumHumansMaleMiddle AgedProstatic NeoplasmsReceptors, AndrogenUnited StatesWhite PeopleAR protein, humanCadmiumReceptors, AndrogenAfrican AmericanAndrogen receptorCadmiumHeavy metalProstate cancer

Identifiers

PMID29773186
PMCPMC5985809
OpenAlexW2798228995

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.